Ovation Science Inc.

Equities

OVAT

CA69016D1087

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange 12:02:21 17/05/2024 am IST 5-day change 1st Jan Change
0.05 CAD 0.00% Intraday chart for Ovation Science Inc. -9.09% +42.86%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Ovation Science Inc. Science Expands Market Reach with Exclusive Canadian License Agreement CI
Ovation Science Inc. announced that it has received $0.05 million in funding CI
Ovation Science Inc. announced that it expects to receive $0.05 million in funding CI
Ovation Science Inc. announced that it expects to receive CAD 0.0675 million in funding CI
Ovation Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Ovation Science Inc. Signs License Agreement with Planet 13 Holdings, Inc CI
Ovation Science Inc. Announces Executive Changes CI
Ovation Science Inc. Announces Board Changes CI
Ovation Science Inc. announced that it has received CAD 0.2 million in funding CI
Ovation Science Inc. announced that it expects to receive CAD 0.2 million in funding CI
Ovation Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ovation Science Inc. Signs Exclusive License Agreement for Its Topical Transdermal Cannabis Products for Pennsylvania CI
Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Ovation Science Announces International Supply and Distribution Agreement CI
Ovation Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Ovation Science Inc. Significantly Expands its Topical/Transdermal Cannabis Product Distribution in Four US States CI
Ovation Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Ovation Science Inc. Auditor Raises 'Going Concern' Doubt CI
Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Ovation Science Develops New High Dose CBD Formulations for Health and Wellness, Beauty Lines MT
Ovation Science Inc. Provides an Update on Its Topical Cannabis Research and Development Efforts CI
Ovation Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Chart Ovation Science Inc.
More charts
Ovation Science Inc. is a Canada-based research and development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. It manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skin care products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers health and wellness products enhanced with hemp-derived CBD and delivered by patented Invisicare skin technology.
More about the company
  1. Stock Market
  2. Equities
  3. OVAT Stock
  4. News Ovation Science Inc.
  5. Ovation Science Develops New High Dose CBD Formulations for Health and Wellness, Beauty Lines
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW